"I want to start with some very good news. We are now acknowledging what was the third vaccine "of Koviak", it was developed by the Center Chumakova," — said Mishustin.
The first 120 thousand doses of the Kovivak vaccine will be launched into civilian circulation in mid-March.
Mishustin also said that " it is now very important that after the control procedure is completed, the entire chain is built to maximize the production of this vaccine."
"This, of course, will require, among other things, appropriate adjustments to our vaccine distribution system. The main thing is that this does not affect the quality. I would ask [Deputy Prime Minister] Tatyana Alekseevna [Golikova] and colleagues to adjust the relevant plans, " the prime minister said.
The process of vaccination against coronavirus in Russia is quite successful, the head of the Cabinet of Ministers noted. At the same time, Mishustin called on the regional authorities to monitor the timely delivery of drugs and the organization of the vaccination process on the ground. He also noted that the emergence of yet another Russian vaccine "of Koviak" "shall not reduce the rate of production" of other drugs from the coronavirus.
Mishustin stressed that Russia is currently the only country that has three vaccines for the prevention of coronavirus infection.
Russia was the first country in the world to register a coronavirus vaccine, called Sputnik V, on August 11, 2020. The drug was developed by the N. F. Gamalei National Research Center for Epidemiology and Microbiology. "Apiversion" from the state scientific center of the "Vector" in October of that same year, he became the second Russian vaccine against the coronavirus that have received the check.
"Kovivak" of the Chumakov Center is an inactivated whole-virion vaccine against coronavirus infection. Such drugs use either artificially weakened viruses that are not able to cause the disease, or already killed (inactivated).